Protagenic Advances PT00114 Toward FDA IND Submission
New York, New York, USA, August 20, 2026 Protagenic Therapeutics, a clinical-stage biopharmaceutical company developing peptide-based treatments for stress-related...
Healthcare Investment
Advertisement
Werewolf Therapeutics and Ambros Announce $150M Merger
Waltham, Massachusetts, USA, and San Diego, California, USA, August 21, 2026 Werewolf Therapeutics and Ambros Therapeutics have announced a...
WindRose Recapitalizes Verified Clinical Trials to Fuel Growth
New York, August 6, 2026 WindRose Health Investors, LLC has completed the recapitalization of Verified Clinical Trials, LLC (VCT),...
Moderna Begins Phase 1 Trial for Ebola mRNA Vaccine
Cambridge, Massachusetts – August 4, 2026 Moderna, Inc. has announced the initiation of a Phase 1 clinical trial evaluating...
SystImmune Launches Global Phase 3 Trial of BL-M14D1
Redmond, Washington, August 5, 2026 SystImmune, Inc., a clinical-stage biotechnology company and subsidiary of Biokin, has announced that the...
Advertisements
Integer to Be Acquired by KKR in $5.7 Billion Deal
Plano, Texas & New York – August 3, 2026 Integer Holdings Corporation, one of the world’s largest medical device...
Caldera, Synlogic Unite in $278M Biotech Merger
CAMBRIDGE, Mass., July 29, 2026 Synlogic, Inc. and Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement...
Bayer Secures €3 Billion Apollo Investment for LARC Business
LEVERKUSEN, Germany, July 10, 2026 Bayer AG has announced a landmark €3.0 billion equity investment agreement with global asset...
Healome Therapeutics Secures £2M to Advance Eye Drop Technology
BIRMINGHAM, United Kingdom, July 7, 2026 Healome Therapeutics, a University of Birmingham spinout developing an innovative eye-drop matrix technology...
Regal Healthcare Capital Closes $610 Million Fund IV
NEW YORK, July 7, 2026 Regal Healthcare Capital Partners has successfully completed the final close of Fund IV, securing...
Advertisement
